Sheaff Brock Investment Advisors, LLC Vertex Pharmaceuticals Inc Transaction History
Sheaff Brock Investment Advisors, LLC
- $1.08 Billion
- Q1 2025
A detailed history of Sheaff Brock Investment Advisors, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Sheaff Brock Investment Advisors, LLC holds 1,454 shares of VRTX stock, worth $532,949. This represents 0.07% of its overall portfolio holdings.
Number of Shares
1,454
Previous 1,138
27.77%
Holding current value
$532,949
Previous $458,000
53.71%
% of portfolio
0.07%
Previous 0.04%
Shares
12 transactions
Others Institutions Holding VRTX
# of Institutions
1,816Shares Held
232MCall Options Held
1.49MPut Options Held
1.07M-
Capital World Investors Los Angeles, CA28.5MShares$10.5 Billion2.34% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.5MShares$8.61 Billion0.21% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$7.81 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA14.5MShares$5.33 Billion1.6% of portfolio
-
State Street Corp Boston, MA11.8MShares$4.32 Billion0.24% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $94.1B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...